Preliminary investigations point to an isolated event, says MHRA
Baxter is recalling a batch of Cernevit powder for solution for injection or infusion as a precautionary measure after receiving two complaints of glass particles in vials.
The Medicines and Healthcare products Regulatory Agency (MHRA) said based on the preliminary investigations the issue is 'an isolated event', but Baxter has decided as a precautionary measure to recall the batch.
In a statement, the company said: 'At Baxter, patient safety is our priority and we have therefore issued a voluntary recall on a specific lot of Cernevit. Customers are asked to review any product they may have in their inventory and remove this from use.
'A full investigation is being undertaken by Baxter and the manufacturer of this product to establish the cause and identify any measures which may need to be put in place to avoid this happening in the future.'